Latest news with #Axtria
Yahoo
24-07-2025
- Business
- Yahoo
Axtria Recognized in Two Gartner® Hype Cycle™ Reports for 2025 for Advancing Data Science and Analytics in Life Sciences
BERKELEY HEIGHTS, N.J., July 24, 2025 /PRNewswire/ -- Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, has been recognized in two Gartner® Hype Cycle™ reports for 2025: the Gartner® Hype Cycle™ for Life Science Enterprise Technologies, 2025 and the Gartner® Hype Cycle™ for Healthcare and Life Science Data, Analytics and AI, 2025. Axtria is named for the third year in Healthcare and Life Science Data, Analytics, and AI for Citizen Data Science. In our view, Axtria's inclusion in both Hype Cycle™ reports highlights the growing impact of its AI-powered platforms and products, which embed agentic AI to deliver intelligent automation, contextual decision support, and conversational analytics. These innovations enable business users to act with autonomy, speed, and precision. Gartner® Hype Cycle™ for Life Science Enterprise Technologies, 2025 Category - Citizen Data Science in HCLS Category - Augmented Analytics in LS Gartner® Hype Cycle™ for Healthcare and Life Science Data, Analytics and AI, 2025 Category - Augmented Analytics in LS Axtria has been recognized in three reports by Gartner®, following its inclusion in six technology categories in the Gartner® Hype Cycle™ for Life Science Commercial Operations reports in 2024 The 2025 Hype Cycle™ reports provide critical guidance to CIOs on technologies that can reshape their enterprises in the years ahead. We believe Axtria's inclusion reflects its commitment to accelerating data-driven transformation and making advanced analytics more accessible across life sciences enterprises. Empowering Every User with Citizen Data Science: In the Citizen Data Science in Healthcare and Life Sciences category, Axtria is recognized for helping non-technical business users leverage advanced analytics. By simplifying access and closing the talent gap, Axtria empowers professionals across all business functions to generate actionable insights and drive meaningful outcomes. Revolutionizing Data Storytelling with Augmented Analytics: In the Augmented Analytics in Life Sciences category, Axtria stands out for innovating how organizations engage with data. Axtria's AI-powered platforms, leveraging generative and agentic AI, deliver conversational interfaces, automated insights, and data storytelling. These capabilities move organizations beyond static dashboards and towards dynamic, real-time decision-making. "As a market leader in AI-powered commercial solutions for life sciences, our AI-first platforms are built with embedded agentic AI capabilities that empower users to not only understand data, but act on it in real-time," said Jaswinder "Jassi" Chadha, CEO of Axtria. "In my opinion this recognition reinforces our commitment to democratizing advanced analytics and driving meaningful outcomes across the industry." For more information about how Axtria can support your organization's Agentic AI journey, please visit GARTNER is a registered trademark and service mark of Gartner and Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. About Axtria's Products and Solutions Axtria is proud to work with 16 of the top 20 life sciences companies globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria is our agentic platform, featuring more than 30 agents, apps, and APIs, along with a full experimentation environment to find the perfect solution for unique business challenges. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration. About Axtria Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit View original content to download multimedia: SOURCE Axtria, Inc.
Yahoo
11-06-2025
- Business
- Yahoo
Axtria Ignite 2025: Defining Leadership in the Agentic AI Era for the Life Sciences Industry
Axtria Ignite 2025 Champions Life Sciences Innovation with a Focus on AI-driven transformations, Patient-Centricity, and Next-Generation Therapies Honoring Excellence: Ignite Leadership Awards Celebrate Trailblazing Industry Leaders Driving Impact and Paving the Path for the Industry Breakthrough Dialogues: 25 Impactful Sessions Spotlight the Convergence of AI, Data, and Therapeutic Innovation in the Agentic Era BERKELEY HEIGHTS, N.J., June 11, 2025 /PRNewswire/ -- Axtria Inc., an AI-first data analytics company empowering the life sciences industry, successfully hosted Axtria Ignite 2025, its flagship annual conference that brought together over 400 senior industry leaders, innovators, and changemakers on June 4-5 in Princeton, N.J. "The life sciences industry stands at the crossroads of unprecedented transformation. At Axtria Ignite 2025, we didn't just talk about what's possible; we explored what's next. From Agentic AI to patient-centric strategies, we are proud to lead this conversation and enable our clients to drive change at speed and scale," said Jaswinder Chadha, President and CEO of Axtria. "This year's event reflects our deep commitment to shaping a more intelligent, agile, and impactful future for healthcare." Axtria Ignite 2025 spotlighted three transformative themes in life sciences: new commercialization strategies for next-gen therapies like rare, orphan, cell, and gene treatments; keeping patients at the heart of operations to drive meaningful impact; and the rapid shift toward GenAI and Agentic AI, with real-world case studies revealing both successes and lessons learned. The conference featured several sessions that were a mix of presentations, panels, workshops, and roundtables, with over 50 speakers from the world's top life sciences companies. It included demo stations for the latest Agentic Innovations in Axtria's products and evening receptions that sprinkled some fun along with networking. Axtria also recognized outstanding industry leadership through its annual Ignite Leadership Award. This year's honorees were Greg Meyers, EVP and Chief Digital and Technology Officer, Bristol Myers Squibb; Ritesh Mehra, Chief Financial Officer, Ferring Pharmaceuticals U.S.; Madhavi Ramakrishna, Senior Vice President of Enterprise AI and Chief Digital and Technology Officer for Commercial, GSK; Stephanie Odutola, Executive Director of U.S. Sales Force Operations, AstraZeneca; and Vikram Singh, Vice President and Global Head of Commercial IT Data Analytics and DSAI, Novartis. For more information about how Axtria can support your organization's Agentic AI journey, please visit About Axtria's Products and Solutions Axtria is proud to work with 16 of the top 20 life sciences companies globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria is our agentic platform, featuring more than 30 agents, apps, and APIs, along with a full experimentation environment to find the perfect solution for unique business challenges. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration. About Axtria Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit View original content to download multimedia: SOURCE Axtria, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-05-2025
- Business
- Yahoo
Axtria Releases New Customer Engagement Planning and Execution Benchmarking Study for Life Sciences
Study reveals increased automation, trust in NBA programs, and growing adoption of dynamic targeting among leading U.S. life sciences organizations BERKELEY HEIGHTS, N.J., May 8, 2025 /PRNewswire/ -- Axtria Inc., an AI-first data analytics innovator transforming life sciences, today released the findings of its new Customer Engagement Planning and Execution Benchmarking Study. The study, based on anonymized data from 16 leading U.S. life sciences companies and over 8,300 field representatives across 57 business units, presents an in-depth view of evolving customer engagement strategies and operational execution practices. "Life sciences companies are clearly accelerating their shift toward intelligent, data-driven engagement," said Asheesh Sharma, Head of Commercial Excellence at Axtria. "This study offers a valuable pulse on how commercial organizations are rethinking execution strategies by embracing automation, boosting trust in AI recommendations, and progressively adopting dynamic approaches to targeting and planning." Key Highlights from the Study: Omnichannel Engagement Maturity: In 2024, 20% of companies with omnichannel programs have fully scaled engagement platforms at an advanced stage—more than double the 9% reported in 2023. This growth is underpinned by stronger cross-functional collaboration and a strategic pivot—80% of surveyed companies now prioritize automation across key functions to drive omnichannel execution. Next Best Action (NBA): Only 44% of companies that have implemented NBA programs say their reps trust the recommendations. Dynamic Targeting Gains Traction: Adoption of dynamic targeting among large pharmaceutical companies rose from 17% in 2023 to 25% in 2024, with 75% of these being refreshed monthly to adapt to the changing market dynamics. Call planning: Reps average six HCP calls per day, with oncology reps recording the lowest call volumes—reflecting the complexity and specialized nature of their engagements. Segmentation and Targeting Practices: 64% of business units refresh customer segments quarterly, though adoption of advanced segmentation using AI/ML models remains limited to 17%. Axtria's benchmarking study serves as a vital tool for commercial operations and brand strategy teams aiming to align with industry-leading practices in omnichannel execution, segmentation, and field rep enablement. About Axtria's Products and Solutions Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria is our agentic platform, featuring more than 30 agents, apps, and APIs, along with a full experimentation environment to find the perfect solution for unique business challenges. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration. About Axtria Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit View original content to download multimedia: SOURCE Axtria, Inc.
